vTv Therapeutics Inc - Class A - Çeyreklik Nakit Akışı (NASDAQ:VTVT) | MetaTrader

Tam grafiği aç

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

Toplam varlıklar 38.27 M32.03 M26.45 M99.49 M89.9 M Toplam yükümlülükler 23.96 M23.13 M24.04 M28.95 M25.46 M Total equity 14.3 M8.9 M2.4 M70.54 M64.44 M Total liabilities & shareholders' equities 38.27 M32.03 M26.45 M99.49 M89.9 M Total debt 0——360 K— Net debt -36.75 M——-98.14 M—

Haberler

BTIG, vTv Therapeutics için Al tavsiyesini yineledi

Evercore ISI, vTv Therapeutics hissesine alım önerisiyle başladı

Evercore ISI initiates vTv Therapeutics stock with outperform rating

BTIG, vTv Therapeutics için Al tavsiyesini yineledi, 49 dolar hedef korundu

BTIG reiterates Buy on vTv Therapeutics stock, $49 target maintained

VTv Stock: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst (NASDAQ:VTVT)

vTv Therapeutics, Newsoara Biopharma ile HPP737 lisans anlaşmasını genişletti

vTv Therapeutics expands HPP737 license agreement with Newsoara Biopharma

vTv expands Newsoara license deal for PDE4 inhibitor to global rights

Roth/MKM, vTv Therapeutics hissesi için Alım tavsiyesiyle analize başladı

Roth/MKM initiates coverage on vTv Therapeutics stock with Buy rating

This MasTec Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Decoy Therapeutics (NASDAQ:DCOY), e.l.f. Beauty (NYSE:ELF)